Concepedia

Carlos Bonilla

CB

7

Publications

511

Citations

7

H-Index

1991

Active since

Affiliations

Instituto Nacional de Cancerología(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Universidad El Bosque

Universidad Nacional de Colombia

National Taiwan University Hospital

Carlos Bonilla is an author at Instituto Nacional de Cancerología specializing in medicine, oncology, and obstetrics.

ORCID

Top concepts

Publications per year

1991–2023

7

Publications

7

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

, , +10

Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study

Do‐Youn Oh, Alain P. Algazi, Jaume Capdevila et al. · Cancer · 2023 · 48 citations · Full text

Use of erlotinib throughout pregnancy: A case-report of a patient with metastatic lung adenocarcinoma

Giovanna Rivas, Néstor Llinás Quintero, Carlos Bonilla et al. · Lung Cancer · 2012 · 35 citations

, , +4

Fragmentation of Care and Its Association With Survival and Costs for Patients With Breast Cancer in Colombia

Óscar Gamboa, Giancarlo Buitrago, Andrés Felipe Patiño Benavidez et al. · JCO Global Oncology · 2023 · 21 citations · Full text

Assessment of luteal function after surgical tubal sterilization

J. Garza‐Flores, L. Vázquez-Estrada, A. Reyes et al. · Advances in Contraception · 1991 · 19 citations

, , +3

Rows per page

1–5 of 7